Som det kan forventes med enhver vasodilator behandling, sås en øget hyppighed af hypotension og nedsat nyrefunktion i forbindelse med Zestril behandling, men medførte ikke en proportione l stigning i mortalitet.
As would be expected from any vasodilator treatment, increased incidences of hypotension and renal dysfunction were associated with Zestril treatment but these were not associated with a proportional increase in mortality.